Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lakshmi Reddy

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Communications Biology|March 20, 2026
Ref-1 drives ulcerative colitis induced systemic defects in hematopoietic cellsRamesh Kumar, Rahul Kanumuri, Sarah S Burns, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2023
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemiaSanthosh Kumar Pasupuleti, Karen Chao, Baskar Ramdas, et al.
Molecular Cancer Therapeutics|October 18, 2013
ATP citrate lyase mediates resistance of colorectal cancer cells to SN38Yunfei Zhou, Lakshmi Reddy Bollu, Federico Tozzi, et al.
Molecular Endocrinology (Baltimore, Md.)|August 26, 2015
Identification of a Novel Coregulator, SH3YL1, That Interacts With the Androgen Receptor N-TerminusAlicia M Blessing, Sathya Ganesan, Kimal Rajapakshe, et al.
Plos One|December 15, 2015
Alcohol Regulates Genes that Are Associated with Response to Endocrine Therapy and Attenuates the Actions of Tamoxifen in Breast Cancer CellsNicholes R Candelaria, Ryan Weldon, Selvaraj Muthusamy, et al.
JCI Insight|March 28, 2023
Loss of Dnmt3a impairs hematopoietic homeostasis and myeloid cell skewing via the PI3Kinase pathwayLakshmi Reddy Palam, Baskar Ramdas, Katelyn Pickerell, et al.
The Journal of Clinical Investigation|June 23, 2026
Targeting GLP1R and IL17A suppresses obesity-induced leukemia in an oncogenic PTPN11 mutation-driven modelReuben Kapur, Linke Li, Rahul Kanumuri, et al.
Blood|June 3, 2026
Therapeutic Targeting of IL-17A-Driven PTGS2/NLRP3 Inflammasome Activation in Juvenile Myelomonocytic LeukemiaSanthosh Kumar Pasupuleti, Baskar Ramdas, Kanaka Sai Ram Padam, et al.
Oncogenesis|January 24, 2018
Targeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and AktRajasekhara Reddy Katreddy, Lakshmi Reddy Bollu, Fei Su, et al.
JCI Insight|February 23, 2018
Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathwayLakshmi Reddy Palam, Raghuveer Singh Mali, Baskar Ramdas, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Communications Biology|March 20, 2026
Ref-1 drives ulcerative colitis induced systemic defects in hematopoietic cellsRamesh Kumar, Rahul Kanumuri, Sarah S Burns, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2023
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemiaSanthosh Kumar Pasupuleti, Karen Chao, Baskar Ramdas, et al.
Molecular Cancer Therapeutics|October 18, 2013
ATP citrate lyase mediates resistance of colorectal cancer cells to SN38Yunfei Zhou, Lakshmi Reddy Bollu, Federico Tozzi, et al.
Molecular Endocrinology (Baltimore, Md.)|August 26, 2015
Identification of a Novel Coregulator, SH3YL1, That Interacts With the Androgen Receptor N-TerminusAlicia M Blessing, Sathya Ganesan, Kimal Rajapakshe, et al.
Plos One|December 15, 2015
Alcohol Regulates Genes that Are Associated with Response to Endocrine Therapy and Attenuates the Actions of Tamoxifen in Breast Cancer CellsNicholes R Candelaria, Ryan Weldon, Selvaraj Muthusamy, et al.
JCI Insight|March 28, 2023
Loss of Dnmt3a impairs hematopoietic homeostasis and myeloid cell skewing via the PI3Kinase pathwayLakshmi Reddy Palam, Baskar Ramdas, Katelyn Pickerell, et al.
The Journal of Clinical Investigation|June 23, 2026
Targeting GLP1R and IL17A suppresses obesity-induced leukemia in an oncogenic PTPN11 mutation-driven modelReuben Kapur, Linke Li, Rahul Kanumuri, et al.
Blood|June 3, 2026
Therapeutic Targeting of IL-17A-Driven PTGS2/NLRP3 Inflammasome Activation in Juvenile Myelomonocytic LeukemiaSanthosh Kumar Pasupuleti, Baskar Ramdas, Kanaka Sai Ram Padam, et al.
Oncogenesis|January 24, 2018
Targeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and AktRajasekhara Reddy Katreddy, Lakshmi Reddy Bollu, Fei Su, et al.
JCI Insight|February 23, 2018
Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathwayLakshmi Reddy Palam, Raghuveer Singh Mali, Baskar Ramdas, et al.
Pageof 7